𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA)

✍ Scribed by Shafaat Rabbani; Penelope Harakidas; Donald J. Davidson; Jack Henkin; Andrew P. Mazar

Book ID
102867437
Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
934 KB
Volume
63
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of the invasion capacity of c
Inhibition of the invasion capacity of carcinoma cells by WX-UK1, a novel synthetic inhibitor of the urokinase-type plasminogen activator system
✍ Suna Ertongur; Stephan Lang; Brigitte Mack; Katja Wosikowski; Bernd Muehlenweg; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 803 KB

## Abstract The overall survival rate of patients suffering from carcinomas has remained poor and nearly unchanged over the last decades. This is mainly due to the so‐called minimal residual disease, __i.e__., remaining tumor cells that overcome surgery and/or radiotherapy and are the cause of loco

Novel inhibitors of urokinase-type plasm
Novel inhibitors of urokinase-type plasminogen activator and matrix metalloproteinase expression in metastatic cancer cell lines
✍ Kristina Cakarovski; Jenny Y. Leung; Christina Restall; Anna Carin-Carlson; Euni πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 339 KB πŸ‘ 1 views

## Abstract The plasminogen‐activating (PA) and matrix metalloproteinase (MMP) enzyme systems are implicated in proteolytic turnover of the extracellular matrix (ECM) associated with biologic processes including wound healing, inflammation and angiogenesis. Aberrant expression of components of the

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in benign, borderline, malignant primary and metastatic ovarian tumors
✍ Maria E. L. van der Burg; Sonja C. Henzen-Logmans; Els M. J. J. Berns; Wim L. J. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 620 KB

Elevated levels of expression of the urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 have shown to be related to poor prognosis in a variety of cancer types. In the present study, cytosolic levels of uPA and PAI-1 were determined with enzyme-linked immunosorbent assays in cytosols